Kelyniam Global (KLYG, $0.13) was a top loser over the last three months, falling -5 to $0.13 per share. A.I.dvisor analyzed 392 stocks in the Medical Specialties Industry for the 3-month period ending May 28, 2025, and found that of them (3) exhibited an Uptrend while of them (6) demonstrated a Downtrend.